GoINPHARMA GmbH, the Germany-based company that provides news, information and analysis to pharma professionals, and DrugPatentWatch, the Washington-based company founded by Yali Friedman, Ph.D., that provides full consultancy services on global drug patents and generic entry to clients throughout the drug discovery-development-delivery chain, have agreed on a business cooperation that is aimed to support professionals active in the healthcare sector//healthcare professionals that want to exploit the potential of their pipelines.
“The pharmaceutical sector has become extremely complex and it has become paramount for companies –whatever the size- to understand the value and the potential of their patents and technological pipelines. Throughout this agreement we will facilitate the process of patent exploitation and give access to a team of experts”, says Dr. Andreas Rückemann, CEO of GoINPHARMA GmbH. “The agreement gives the opportunity to reach out companies that have just started to ponder the real value of their technological portfolio and gives a clear overview of the possibility for further exploitation” said Yali Friedman, Ph.D. founder of Thinkbiotech and DrugPatentWatch.
The two companies will give regular updates about new tools and services that will be developed during the cooperation.